No black box warning on record for Progesterone

As of the latest FDA labeling reviewed, Progesterone (PROGESTERONE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Progesterone medicine page for the complete safety profile.

Other warnings & precautions

WARNINGS See BOXED WARNING . 1. Cardiovascular disorders An increased risk of pulmonary embolism, deep vein thrombosis (DVT), stroke, and myocardial infarction has been reported with estrogen plus progestin therapy. Should any of these occur or be suspected, estrogen with progestin therapy should be discontinued immediately. Risk factors for arterial vascular disease (for example, hypertension, di

No black box warning on record for Progesterone

Other warnings & precautions

WARNINGS See BOXED WARNING . 1. Cardiovascular disorders An increased risk of pulmonary embolism, deep vein thrombosis (DVT), stroke, and myocardial infarction has been reported with estrogen plus progestin therapy. Should any of these occur or be suspected, estrogen with progestin therapy should be discontinued immediately. Risk factors for arterial vascular disease (for example, hypertension, di

Progesterone Black Box Warning

No black box warning on record for Progesterone

Other warnings & precautions

Progesterone Black Box Warning

No black box warning on record for Progesterone

Other warnings & precautions